BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 31201325)

  • 1. The pore structure of Clostridium perfringens epsilon toxin.
    Savva CG; Clark AR; Naylor CE; Popoff MR; Moss DS; Basak AK; Titball RW; Bokori-Brown M
    Nat Commun; 2019 Jun; 10(1):2641. PubMed ID: 31201325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clostridium perfringens epsilon toxin H149A mutant as a platform for receptor binding studies.
    Bokori-Brown M; Kokkinidou MC; Savva CG; Fernandes da Costa S; Naylor CE; Cole AR; Moss DS; Basak AK; Titball RW
    Protein Sci; 2013 May; 22(5):650-9. PubMed ID: 23504825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clostridium perfringens epsilon toxin: the third most potent bacterial toxin known.
    Alves GG; Machado de Ávila RA; Chávez-Olórtegui CD; Lobato FC
    Anaerobe; 2014 Dec; 30():102-7. PubMed ID: 25234332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epsilon toxin: a fascinating pore-forming toxin.
    Popoff MR
    FEBS J; 2011 Dec; 278(23):4602-15. PubMed ID: 21535407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between in vitro cytotoxicity and in vivo lethal activity in mice of epsilon toxin mutants from Clostridium perfringens.
    Dorca-Arévalo J; Pauillac S; Díaz-Hidalgo L; Martín-Satué M; Popoff MR; Blasi J
    PLoS One; 2014; 9(7):e102417. PubMed ID: 25013927
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Kumar S; Behera SK; Gururaj K; Chaurasia A; Murmu S; Prabha R; Angadi UB; Pawaiya RS; Rai A
    J Biomol Struct Dyn; 2024 Mar; 42(5):2257-2269. PubMed ID: 37129165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CodY is a global regulator of virulence-associated properties for Clostridium perfringens type D strain CN3718.
    Li J; Ma M; Sarker MR; McClane BA
    mBio; 2013 Oct; 4(5):e00770-13. PubMed ID: 24105766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and functional analysis of the pore-forming toxin NetB from Clostridium perfringens.
    Yan XX; Porter CJ; Hardy SP; Steer D; Smith AI; Quinsey NS; Hughes V; Cheung JK; Keyburn AL; Kaldhusdal M; Moore RJ; Bannam TL; Whisstock JC; Rood JI
    mBio; 2013 Feb; 4(1):e00019-13. PubMed ID: 23386432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New insights into Clostridium perfringens epsilon toxin activation and action on the brain during enterotoxemia.
    Freedman JC; McClane BA; Uzal FA
    Anaerobe; 2016 Oct; 41():27-31. PubMed ID: 27321761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clostridium perfringens epsilon toxin mutant Y30A-Y196A as a recombinant vaccine candidate against enterotoxemia.
    Bokori-Brown M; Hall CA; Vance C; Fernandes da Costa SP; Savva CG; Naylor CE; Cole AR; Basak AK; Moss DS; Titball RW
    Vaccine; 2014 May; 32(23):2682-7. PubMed ID: 24709588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cryo-EM structures reveal translocational unfolding in the clostridial binary iota toxin complex.
    Yamada T; Yoshida T; Kawamoto A; Mitsuoka K; Iwasaki K; Tsuge H
    Nat Struct Mol Biol; 2020 Mar; 27(3):288-296. PubMed ID: 32123390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the channel-forming domain of Clostridium perfringens Epsilon-toxin (ETX).
    Knapp O; Maier E; Benz R; Geny B; Popoff MR
    Biochim Biophys Acta; 2009 Dec; 1788(12):2584-93. PubMed ID: 19835840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A low-toxic site-directed mutant of Clostridium perfringens ε-toxin as a potential candidate vaccine against enterotoxemia.
    Li Q; Xin W; Gao S; Kang L; Wang J
    Hum Vaccin Immunother; 2013 Nov; 9(11):2386-92. PubMed ID: 23835363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central residues of the amphipathic β-hairpin loop control the properties of Clostridium perfringens epsilon-toxin channel.
    Knapp O; Maier E; Piselli C; Benz R; Hoxha C; Popoff MR
    Biochim Biophys Acta Biomembr; 2020 Sep; 1862(9):183364. PubMed ID: 32450142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Mutants of Epsilon Toxin from
    Dorca-Arévalo J; Gómez de Aranda I; Blasi J
    Toxins (Basel); 2022 Apr; 14(4):. PubMed ID: 35448898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Myelin and Lymphocyte Protein MAL Is Required for Binding and Activity of Clostridium perfringens ε-Toxin.
    Rumah KR; Ma Y; Linden JR; Oo ML; Anrather J; Schaeren-Wiemers N; Alonso MA; Fischetti VA; McClain MS; Vartanian T
    PLoS Pathog; 2015 May; 11(5):e1004896. PubMed ID: 25993478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epsilon toxin is essential for the virulence of Clostridium perfringens type D infection in sheep, goats, and mice.
    Garcia JP; Adams V; Beingesser J; Hughes ML; Poon R; Lyras D; Hill A; McClane BA; Rood JI; Uzal FA
    Infect Immun; 2013 Jul; 81(7):2405-14. PubMed ID: 23630957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of
    Marshall S; McGill B; Morcrette H; Winlove CP; Chimerel C; Petrov PG; Bokori-Brown M
    Toxins (Basel); 2022 Nov; 14(11):. PubMed ID: 36356007
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification of tyrosine 71 as a critical residue for the cytotoxic activity of Clostridium perfringens epsilon toxin towards MDCK cells.
    Jiang Z; Chang J; Wang F; Yu L
    J Microbiol; 2015 Feb; 53(2):141-6. PubMed ID: 25626370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clostridium perfringens Epsilon Toxin Mutant I51C as a Recombinant Vaccine Candidate Against Enterotoxemia.
    Nakhaipour E; Kariminik A; Alimolaei M; Bafti MS
    Clin Lab; 2024 Feb; 70(2):. PubMed ID: 38345990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.